rs199816697
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BP4_Strong
The ENST00000248244.6(TICAM1):c.238G>A(p.Val80Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000701 in 1,609,628 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
ENST00000248244.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TICAM1 | NM_182919.4 | c.238G>A | p.Val80Met | missense_variant | 2/2 | ENST00000248244.6 | NP_891549.1 | |
TICAM1 | NM_001385678.1 | c.196G>A | p.Val66Met | missense_variant | 3/3 | NP_001372607.1 | ||
TICAM1 | NM_001385679.1 | c.103G>A | p.Val35Met | missense_variant | 2/2 | NP_001372608.1 | ||
TICAM1 | NM_001385680.1 | c.-72+244G>A | intron_variant | NP_001372609.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TICAM1 | ENST00000248244.6 | c.238G>A | p.Val80Met | missense_variant | 2/2 | 1 | NM_182919.4 | ENSP00000248244 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000677 AC: 103AN: 152244Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.000659 AC: 159AN: 241402Hom.: 0 AF XY: 0.000721 AC XY: 95AN XY: 131776
GnomAD4 exome AF: 0.000703 AC: 1025AN: 1457266Hom.: 1 Cov.: 81 AF XY: 0.000707 AC XY: 513AN XY: 725120
GnomAD4 genome AF: 0.000676 AC: 103AN: 152362Hom.: 1 Cov.: 32 AF XY: 0.000617 AC XY: 46AN XY: 74496
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:2
Likely benign, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, University Medical Center Utrecht | - | - - |
Likely benign, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Uncertain significance, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Herpes simplex encephalitis, susceptibility to, 4 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 05, 2022 | This sequence change replaces valine, which is neutral and non-polar, with methionine, which is neutral and non-polar, at codon 80 of the TICAM1 protein (p.Val80Met). This variant is present in population databases (rs199816697, gnomAD 0.1%), and has an allele count higher than expected for a pathogenic variant. This variant has not been reported in the literature in individuals affected with TICAM1-related conditions. ClinVar contains an entry for this variant (Variation ID: 540506). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The methionine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at